| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |